{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:45:41Z","timestamp":1783392341121,"version":"3.54.6"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0098089","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T20:33:19Z","timestamp":1400617999000},"page":"e98089","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Conceptual Framework for Evaluating Impairments in Myasthenia Gravis"],"prefix":"10.1371","volume":"9","author":[{"given":"Carolina","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Kapral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhaya","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"ref1","first-page":"30","article-title":"Measurement in Medicine","volume":"2011","author":"HCW De Vet","year":"2011","journal-title":"Cambridge Univ Pr"},{"key":"ref2","unstructured":"World Health Organization (2001) International Classification of Functioning, Disability and Health (ICF). 1st ed. World Health Organization."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MRR.0b013e32831e4587","article-title":"Disability and functional profiles of patients with myasthenia gravis measured with ICF classification","volume":"32","author":"M Leonardi","year":"2009","journal-title":"Int J Rehab Res 2009"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Howard JF (2012) The diagnosis of myasthenia gravis and other disorders of neuromuscular transmission. In Engel AG (2012) Myasthenia Gravis and Myasthenic Disorders. Oxford University Press. pp. 108\u2013129.","DOI":"10.1093\/med\/9780199738670.003.0005"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kuks JMB, Oosterhuis HJGH (2009) Clinical presentation and epidemiology of myasthenia gravis. In Kaminski HJ (2009) Myasthenia Gravis and Related Disorders. Springer. pp 93\u2013114.","DOI":"10.1007\/978-1-59745-156-7_5"},{"key":"ref6","first-page":"939","article-title":"Effets \u00e0 long terme des \u00e9changes plasmatiques au cours de la myasth\u00e8nie. R\u00e9sultats d'une \u00c8tude randomis\u00e9e","volume":"12","author":"P Gajdos","year":"1983","journal-title":"Presse Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"RS Tindall","year":"1987","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"RJ Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"TM Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1477-7525-8-129","article-title":"Quality of life and life circumstances in German myasthenia gravis patients","volume":"8","author":"S Twork","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1477-7525-3-46","article-title":"Health measurement using the ICF: test-retest reliability study of ICF codes and qualifiers in geriatric care","volume":"3","author":"J Okochi","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"ref12","unstructured":"Zhang Y, Wildemuth BM (2009) Qualitative analysis of content. In Wildemuth BM (Ed.) Applications of social research methods to questions in information and library science. pp308\u2013319. Westport, CT: Libraries Unlimited."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2288-10-22","article-title":"The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its content","volume":"10","author":"LB Mokkink","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2648.1997.t01-25-00999.x","article-title":"Sampling in qualitative research. Purposeful and theoretical sampling; merging or clear boundaries","volume":"26","author":"ITI Coyne","year":"1997","journal-title":"J Adv Nurs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"A Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How Many Interviews Are Enough? An Experiment with Data Saturation and Variability","volume":"18","author":"G Guest","year":"2006","journal-title":"Field Methods"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1440-1614.2002.01100.x","article-title":"Understanding and evaluating qualitative research","volume":"36","author":"E Fossey","year":"2002","journal-title":"Aust N Z J Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process","volume":"62","author":"S Elo","year":"2008","journal-title":"J Adv Nurs"},{"key":"ref20","first-page":"137","article-title":"A reliability study of impairment and disability scales for myasthenia gravis patients","volume":"17","author":"A Romani","year":"2002","journal-title":"Funct Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"UA Besinger","year":"1983","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Mantegazza R, Antozzi C, Peluchetti D (1988) Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol: 449\u2013453.","DOI":"10.1007\/BF00314245"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"DB Sanders","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1545968308315046","article-title":"Fatigue Versus Activity-Dependent Fatigability in Patients With Central or Peripheral Motor Impairments","volume":"22","author":"BH Dobkin","year":"2007","journal-title":"Neurorehabil Neural Repair"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","article-title":"Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy","volume":"80","author":"BM Kluger","year":"2013","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3109\/09638280902893634","article-title":"Identification of international classification of functioning, disability and health relevant categories to describe functioning and disability of patients with myasthenia gravis","volume":"31","author":"M Leonardi","year":"2009","journal-title":"Disabil Rehabil"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nmd.2013.02.008","article-title":"Performance of individual items of the quantitative myasthenia gravis score","volume":"23","author":"TC Barnett","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"D Lashley","year":"2010","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1196\/annals.1254.058","article-title":"Standards of measurements in myasthenia gravis","volume":"998","author":"P Gajdos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","article-title":"Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis","volume":"247","author":"T Sharshar","year":"2000","journal-title":"J Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0098089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:49:55Z","timestamp":1540212595000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0098089"}},"subtitle":[],"editor":[{"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0098089","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}